CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration ; volume:9 ; number:1 ; day:10 ; month:5 ; year:2018 ; pages:1-8 ; date:12.2018
Nature Communications ; 9, Heft 1 (10.5.2018), 1-8, 12.2018
- Urheber
-
Koo, Taeyoung
- Beteiligte Personen und Organisationen
-
Park, Sung Wook
Jo, Dong Hyun
Kim, Daesik
Kim, Jin Hyoung
Cho, Hee-Yeon
Kim, Jeungeun
Kim, Jeong Hun
Kim, Jin-Soo
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-04175-y
- URN
-
urn:nbn:de:101:1-2018070800562328264947
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koo, Taeyoung
- Park, Sung Wook
- Jo, Dong Hyun
- Kim, Daesik
- Kim, Jin Hyoung
- Cho, Hee-Yeon
- Kim, Jeungeun
- Kim, Jeong Hun
- Kim, Jin-Soo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization